Simplex Trading, LLC Cytom X Therapeutics, Inc. Transaction History

Simplex Trading, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$1.21 - $5.13 $2,629 - $11,147	-2,173 Reduced 35.83%	3,891 $4,000
Q1 2024 Apr 25, 2024	BUY	$1.41 - $2.74 $8,550 - $16,615	6,064 New	6,064 $13,000
Q2 2023 Aug 04, 2023	BUY	$1.41 - $1.92 $999 - $1,361	709 New	709 $1,000
Q1 2022 May 02, 2022	SELL	$2.67 - $4.68 $16,431 - $28,800	-6,154 Reduced 99.77%	14 $0
Q2 2021 Aug 12, 2021	BUY	$6.33 - $9.91 $39,043 - $61,124	6,168 New	6,168 $39,000
Q3 2020 Oct 14, 2020	SELL	$6.55 - $8.83 $1,689 - $2,278	-258 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$7.4 - $14.64 $791 - $1,566	-107 Reduced 29.32%	258 $2,000
Q1 2020 Apr 29, 2020	SELL	$3.61 - $8.6 $58,225 - $138,709	-16,129 Reduced 97.79%	365 $2,000
Q4 2019 Feb 05, 2020	BUY	$5.17 - $8.91 $85,273 - $146,961	16,494 New	16,494 $137,000
Q2 2019 Jul 26, 2019	SELL	$9.35 - $11.41 $1,346 - $1,643	-144 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$9.5 - $19.16 $1,368 - $2,759	144 New	144 $0
Q2 2018 Jul 30, 2018	SELL	$21.38 - $29.68 $1,902 - $2,641	-89 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$21.76 - $34.22 $1,936 - $3,045	89 New	89 $2,000
Q4 2017 Jan 10, 2018	SELL	$19.0 - $23.09 $5,510 - $6,696	-290 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$13.53 - $18.17 $3,923 - $5,269	290	290 $5,000

50.7M

112K

8.3K

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $69.9M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.